We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CZG:PSECZCOLT CZ GROUP SE Analysis

Data as of 2026-06-13 - not real-time

$49.32

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Colt CZ Group SE trades well below its intrinsic valuation, offering a compelling margin of safety for value‑oriented investors. The company’s revenue growth remains robust and free cash flow generation supports a healthy dividend payout. With a dividend yield that outpaces many peers and a payout ratio comfortably below half of earnings, the dividend appears sustainable. The balance sheet shows modest leverage, and return metrics indicate efficient use of capital. Technical analysis shows the price hovering near a key support level while the broader trend remains bullish. However, the MACD signals short‑term bearish momentum.
Volume is on an upward trajectory, suggesting accumulating interest despite the bearish histogram. The low beta and modest 30‑day volatility point to a relatively stable price profile. Regulatory considerations inherent to the firearms sector introduce a medium level of uncertainty. Geographic diversification across North America and Europe mitigates region‑specific risks but does not eliminate them. Overall, the stock presents a blend of undervaluation, dividend appeal, and manageable risk, making it attractive for investors with a medium to long horizon.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near technical support
  • increasing trading volume
  • bearish MACD histogram

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • significant valuation gap to intrinsic value
  • sustainable dividend yield
  • strong revenue growth and cash flow

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • long‑term defensive positioning in aerospace & defense
  • continued dividend growth potential
  • robust free cash flow supporting strategic investments

Key Metrics & Analysis

Financial Health

Revenue Growth32.80%
Profit Margin7.62%
P/E Ratio29.5
ROE10.01%
ROA3.55%
Debt/Equity96.23
P/B Ratio0.1
Free Cash Flow$2.7B
Industry P/E30.6

Technical Analysis

TrendBullish
RSI38.6
Support$49.32
Resistance$50.43
MA 20$50.05
MA 50$49.58
MA 200$40.51
MACDBearish
VolumeIncreasing
Fear & Greed Index89.86

Valuation

Fair Value$1,547.24
GradeUndervalued
TypeGrowth
Dividend Yield1.41%

Risk Assessment

Beta0.12
Volatility7.13%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.